Gliclazide格列齐特,21187-98-4

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Gliclazide

CAS No. : 21187-98-4

MCE 国际站：Gliclazide

产品活性：Gliclazide (S1702) 是全细胞的 β 细胞 ATP 敏感型钾流 (potassium currents) 阻断剂，IC₅₀ 为 184 nM，用作降糖药。

研究领域：Membrane Transporter/Ion Channel

作用靶点：Potassium Channel

In Vitro: Gliclazide (S1702) further characterize its mechanism of hypoglycemic effect: the observed improvements in insulin sensitivity and in GLUT4 translocation indicate that gliclazide counters the hydrogen peroxide-induced insulin resistance in 3T3L1 adipocytes and also would further augment the hypoglycemic effect of this drug as insulinotropic sulfonylurea.
Gliclazide blocked whole-cell beta-cell KATP currents with an IC₅₀ of 184 +/- 30 nmol/l (n=6-10) but was much less effective in cardiac and smooth muscle (IC₅₀s of 19.5 +/- 5.4 micromol/l (n=6-12) and 37.9 +/- 1.0 micromol/l (n=5-10), respectively). In all three tissues, the action of the drug on whole-cell KATP currents was rapidly reversible. In inside-out patches on beta-cells, gliclazide (1 micromol/l) produced a maximum of 66 +/- 13 % inhibition (n=5), compared with more than 98 % block in the whole-cell configuration. Gliclazide is a high-potency sulphonylurea which shows specificity for the pancreatic beta-cell KATP channel over heart and smooth muscle. In this respect, it differs from glibenclamide.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  FDA-Approved Drug Library  |  Drug Repurposing Compound Library  |  Anti-diabetic Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Alzheimer's Disease Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Potassium Channel Compound Library  |  Human Metabolite Library  |  Heterocyclic Compound Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Ion Channel Compound Library  |  Nigericin sodium salt  |  Yoda 1  |  BAPTA-AM  |  Minocycline hydrochloride  |  Branaplam  |  Rosuvastatin Calcium  |  SCH-23390 hydrochloride  |  Glibenclamide  |  Quinidine (15% dihydroquinidine)  |  Tetrandrine  |  Carbamazepine  |  20(S)-Ginsenoside Rg3  |  DCPIB  |  E-4031  |  Amiodarone hydrochloride  |  Minoxidil  |  TRAM-34  |  Tannic acid  |  (±)-Naringenin  |  Quinine  |  Terfenadine  |  SKF-96365 hydrochloride  |  Mefloquine hydrochloride  |  4-Aminopyridine  |  GW9508  |  PAP-1  |  Astemizole  |  Flufenamic acid  |  Guanosine 5'-diphosphate disodium salt  |  Tolbutamide

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds